Alpha-1 Antitrypsin Deficiency Drug Enters Ph3 Trial
Grifols enrolled the first patient in its Phase 3 SWIFT-SC clinical trial to evaluate its subcutaneous Alpha1-Proteinase Inhibitor for the treatment of alpha1-antitrypsin (AAT) deficiency.
Category: Products & Treatment
Products & Treatment
Latest
Products & Treatment
Latest
Fifth Annual World Bronchiectasis Day Set for July 1
Global organizations unite to raise awareness and improve care for more than 1 million people living with bronchiectasis.
Products & Treatment
Latest
Capnography and Pulse Oximetry in the PICU
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Industry & Regulatory News
Latest
FDA Clears PanopticAI Respiratory Rate Monitoring
The software-as-a-medical-device allows for contactless measurement of respiratory and pulse rates using only a standard smartphone camera.
Pharmaceuticals
Latest
Positive Ph3 Data for Aspergillosis Antifungal Treatment
Phase 3 trial results indicate a new antifungal medication olorofim is as effective as current standard treatments for invasive aspergillosis with fewer side effects.
Diagnostics & Testing
Latest
First Endobronchial Ultrasound Procedure at New Jersey Medical Center
Hackensack Meridian Pascack Valley Medical Center successfully completed its first endobronchial ultrasound to diagnose pulmonary conditions.
Monitoring & Treatment
Latest
Dynarex Launches POC, Neo/Pediatric Closed Suction Catheters
Dynarex Corp launched a new Resp-O₂ Portable Oxygen Concentrator and a new line of infant- and pediatric-sized closed suction catheters.